Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients: A Randomized Clinical Trial Study
Background: Increase in the prevalence and survival rates has led to the assessment of disease activity and quality of life of SLE patients as targets in treatment. Cholecalciferol was considered as having a role in reducing disease activity and improving quality of life. Methods: A double blind, ra...
Main Authors: | Fiblia Fiblia, Iris Rengganis, Dyah Purnamasari, Alvina Widhani, Teguh H Karjadi, Hamzah Shatri, Rudi Putranto |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2022-07-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | https://actamedindones.org/index.php/ijim/article/view/2074 |
Similar Items
-
A Survey of Systemic Lupus Erythematosus Patients’ Educational Needs
by: Jennifer Josephine, et al.
Published: (2023-12-01) -
Factors Associated with Psychosomatic Disorders Among Systemic Lupus Erythematosus (SLE) Patients During the Coronavirus Disease 2019 (COVID-19) Pandemic
by: Dina Elita, et al.
Published: (2024-07-01) -
Changes in Gut Microbiota and Systemic Inflammation after Synbiotic Supplementation in Patients with Systemic Lupus Erythematosus: A Randomized, Double-Blind, Placebo-Controlled Trial
by: Alvina Widhani, et al.
Published: (2022-10-01) -
Cutaneous lupus erythematosus: An update
by: Carina M Grönhagen, et al.
Published: (2014-01-01) -
Lupus Enteritis: An Uncommon Manifestation of Systemic Lupus Erythematosus as an Initial Presentation
by: Vishal Bodh, et al.
Published: (2017-07-01)